You are here: Industry Insights > England

News List

PAH patients in England denied access to Actelion’s Uptravi on NHS pharmatimes
July 16, 2018
Actelion’s Uptravi will not be funded on the NHS for patients with Pulmonary Arterial Hypertension (PAH), after the drug failed to make it into NHS England’s latest round of specialised commissioning approvals.
NHS England appoints national clinical advisor for primary care pharmatimes
July 16, 2018
NHS England has appointed a specialist GP to encourage the spread of innovations that integrate health and social care throughout England.
NHS England unveils £10m fund to retain GPs pharmatimes
June 06, 2018
NHS England has announced a new initiative to help retain GPs in the shape of a £10 million fund designed to capture those considering leaving general practice.
HIV-preventing drug to be trialed across England pharmafile
August 08, 2017
NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the beginning of a three-year, £10 million trial.
England’s chief medical officer calls for better access to genetic testing pharmaceutical-technology
July 10, 2017
England’s chief medical officer professor Dame Sally Davies has highlighted the need for routine access to genetic testing to improve diagnosis and treatment of cancer in the UK.
HIV cases in gay men fall for the first time in England pharmafile
June 23, 2017
HIV cases in gay men fall for the first time in England
NHS England announces new Five Year Forward View pharmaceutical-technology
April 06, 2017
NHS England has announced the new Five Year Forward View ‘Next Steps’ Plan to further improve cancer survival by an extra 5,000 people.

Previous page 1 2 3 Next page